SOURCE: Axxess Pharma, Inc.

Axxess Pharma, Inc.

June 09, 2014 08:00 ET

Axxess Pharmas TapouT Muscle Recovery Products Gain Significant Sales Momentum in US Market

Products Experience Strong Sales from, and

TORONTO, ON--(Marketwired - Jun 9, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., its TapouT Muscle Recovery line is gaining significant sales momentum in the United States through its placement on, and

The all natural TapouT Muscle Recovery line of sports nutrition products includes supplements and topical sprays to help build muscle and reduce inflammation after intense training sessions.

The tremendous boost in sales on these three platforms in particular comes in the wake of Axxess Pharmas TapouT completely selling out of its first round of product on earlier this year. Manufactured by AllStar Health Brands, Inc., the brand has clearly become a favorite of athletes, bodybuilders and active individuals across the United States.

"Since we first launched our TapouT Muscle Recovery products in the North American market, customers have responded incredibly and our sales are truly booming," said Dr. Daniel Bagi, President of All Star Brands. "Great companies like Ronnie Coleman Nutrition, RevNutrition and GO4itNutrition have given our products outstanding exposure, and we couldn't be more pleased with the progress we've made in just a short amount of time."

TapouT Muscle Recovery products are formulated with a unique blend of seven different oils essential for the promotion of muscle growth in a healthy and sustainable way. The products do not include any chemical bonding agents, making them a healthier option for people looking for a way to build muscle mass.

Rather than thinning the blood to relieve common aches and pains associated with weightlifting and training, TapouT has natural anti-inflammatory properties and uses a mild anesthetic that provides a cooling sensation while numbing pain. It also works to numb pain with all-natural plant-based medical ingredients that open the blood vessels.

The product line was originally developed with mixed martial arts fighters in mind, but quickly became popular with serious athletes across a wide variety of sports. It comes in varieties that include topical ointments and sprays, which the user rubs directly on to sore muscles, and daytime and evening supplements, meant to build muscle with energy boosts during the day and deliver pain relief at night.

For more information on TapouT Muscle Recovery, visit

About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: and

For more information, please visit, or contact Investor Relations at (973) 351-3868.

About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit

Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.

Contact Information